Radiologists look at Vienna

Spring can be felt, though many visitors of ECR 2015 probably only have time to enjoy the floral decorations in the conference center. The program of the conference is packed full of topics that promise exciting days and many discussions.

Session chairman Anwar R. Padhani
Session chairman Anwar R. Padhani
Source: ESR

A major topic of the congress: prostate cancer diagnosis and management. Anwar R. Padhani, consultant radiologist at Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, and Professor of the Institute of Cancer Research, London, thinks that the current situation in prostate cancer diagnosis is a mess for patients: „Men with prostate cancer are both under-diagnosed and over-diagnosed, under-treated and over-treated.“ The reasons for it are manifold. On the one hand, the very controversial PSA level conveys a false sense of safety to many men. Their level may be in the normal range, even though they already have cancer. The opposite is also possible: The value is increased and seems to indicate cancer, but there is no cancer. This is why many men end in OR who instead could have lived without cancer treatment until the rest of their days. On the other hand, biopsy might not always provide an accurate result as well. According to Padhani, a wrong diagnosis occurs in 20 to 30 percent of all cases, because the cancer is simply missed. Radiology therefore focuses on new ultrasonic techniques as well as multi-parameter MRI.

Radiologists have to reconsider ways to treat prostate cancer
For Padhani, the path is clear: “We must change, and for that, we must think differently. Prostate cancer is the last cancer in which imaging is not a key element of the diagnostic pathway. Multi-parametric MRI is becoming a key component of the prostate cancer diagnosis pathway and targeted biopsies of lesions under MRI guidance are likely to become a part of the diagnostic pathway. Tissue preservation, by active surveillance and focal therapy, will reduce the over-treatment burden of localised disease.”

The congress participants are able to get to know which steps this might be in the session NH 9 Image-guided interventions of the prostate on Friday.

 

 

05.03.2015

Read all latest stories

Related articles

Photo

Predictive biomarkers

Immunotherapy follow-up with MRI: the search is on

Immunotherapy is taking center stage in imaging, but patient follow-up with CT is no cookie and may fall short in the peripheral limbs, brain and bone marrow. MRI offers specific benefits in these…

Photo

ECR

Record breaking attendance at the European Congress of Radiology 2016

The European Congress of Radiology (ECR) 2016 took place March 2 to 6 at the Austria Center Vienna. Over the five days, a new record attendance was achieved: 25,998 onsite and online delegates from…

Photo

RSNA 2015

Breast MRI after mammography may identify additional aggressive cancers

Additional breast cancers found with MRI are sometimes larger and potentially more aggressive than those found on mammography, according to a study published online in the journal Radiology.

Related products

Noras – Uni-Lift Prostate Intervention Device

MRT Coils

Noras – Uni-Lift Prostate Intervention Device

NORAS MRI products GmbH
allMRI GmbH – MRI vacuum immobilisation for head coils

Accessories / Complementary systems

allMRI GmbH – MRI vacuum immobilisation for head coils

allMRI GmbH
allMRI GmbH – MRI wheelchair – foldable

Accessories / Complementary systems

allMRI GmbH – MRI wheelchair – foldable

allMRI GmbH
allMRI GmbH – MRI wheeled waste bin – 90 liters

Accessories / Complementary Systems

allMRI GmbH – MRI wheeled waste bin – 90 liters

allMRI GmbH
Beckman Coulter – phi (Prostate Health Index)

Immunochemistry

Beckman Coulter – phi (Prostate Health Index)

Beckman Coulter, Inc.
Beckman Coulter – Remisol Advance

LIS, Middleware, POCT

Beckman Coulter – Remisol Advance

Beckman Coulter, Inc.